(Q37331885)

19 August 2017

Safety review in 10,008 users of lansoprazole in daily practice (English)

1 reference

19 August 2017

A A Claessens

1

1 reference

19 August 2017

E R Heerdink

2

1 reference

19 August 2017

J T Van Eijk

3

1 reference

19 August 2017

C B Lamers

4

1 reference

19 August 2017

H G Leufkens

5

1 reference

19 August 2017

1 September 2000

1 reference

Pharmacoepidemiology and Drug Safety

19 August 2017

1 reference

19 August 2017

9

1 reference

19 August 2017

5

1 reference

19 August 2017

383-391

1 reference

Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs

19 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F1099-1557%28200009%2F10%299%3A5%3C383%3A%3AAID-PDS506%3E3.0.CO%3B2-W

Crossref

reference URL

Omeprazole, H2 blockers, and polyarthralgia: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1557%28200009%2F10%299%3A5%3C383%3A%3AAID-PDS506%3E3.0.CO%3B2-W

Crossref

reference URL

Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1557%28200009%2F10%299%3A5%3C383%3A%3AAID-PDS506%3E3.0.CO%3B2-W

Crossref

reference URL

10.1002/1099-1557(200009/10)9:5<383::AID-PDS506>3.0.CO;2-W

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference